AFT Implements Wingspan Solutions
Wingspan Technology today announced Alliance Foundations Trials, LLC (AFT) selected Wingspan eTMF and SiteZone to create, collect, modify, and manage its clinical trial content. AFT, based in Boston and Chicago, is an academic research organization that develops and conducts cancer clinical trials, working closely with pharmaceutical partners, research collaborators and the Alliance for Clinical Trials in Oncology scientific investigators and institutional member network. AFT selected Wingspan eTMF for its easier-to-use, more transparent and more cost-effective solutions. AFT also implemented SiteZone, Wingspan’s tool for site collaboration, to create more efficient workflows and eliminate the transfer of paper documents between clinical trial sites, CRAs, and the eTMF. “AFT utilizes the Alliance network of sites for all AFT trials. We wanted a system that is easy to use for both our study teams and sites. We found that in Wingspan and Sitezone,” said Monica M. Bertagnolli, MD, President of Alliance Foundation Trials and Group Chair of the Alliance for Clinical Trials in Oncology. “Our goal is to have a single eTMF across our broad portfolio that will support both large and small studies. We believe Wingspan will deliver what we need.“ In order to facilitate a smooth and timely transition, AFT used a four-phase implementation approach. They first implemented Wingspan eTMF, then SiteZone, followed by CTMS integration, and finally migrated all content from their previous system. AFT used a risk-based approach to user acceptance testing, leveraging Wingspan’s UAT accelerator materials. This allowed additional time for user training prior to the official go-live date. About Wingspan Technology, Inc.Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including the Wingspan Life Sciences Solution platform, as well as DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields. About Alliance Foundation Trials, LLC Alliance Foundation Trials, LLC (AFT) seeks to fulfill the vision of the Alliance for Clinical Trials in Oncology to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Established in 2014 as a limited liability corporation, AFT is managed by the Alliance for Clinical Trials in Oncology Foundation, which is its sole member. The AFT operational structure and funding sources are separate from the Alliance clinical trials program funded by the National Cancer Institute (NCI).
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion Trial Data
May 22nd 2025One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.
